Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloé Friedrich

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Diagnostics (Basel, Switzerland)|July 27, 2022
The Mesenchymal Niche in Myelodysplastic SyndromesChloé Friedrich, Olivier Kosmider
Blood|July 3, 2020
A splenic lymphoma/leukemia with a spontaneous blast decrease without treatmentChloé Friedrich, Sylvain Barreau
Annals of Hematology|June 14, 2020
Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndromeChloé Friedrich, Juliette Gay, Anne-Sophie Alary, et al.
Annals of Hematology|October 4, 2022
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromesMeunier Mathieu, Chloé Friedrich, Nicolas Ducrot, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Rheumatology (Oxford, England)|July 2, 2021
Atypical splice-site mutations causing VEXAS syndromeMarie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
BMC Biology|March 9, 2022
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell levelCharles Dussiau, Agathe Boussaroque, Mathilde Gaillard, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
Rheumatology (Oxford, England)|April 9, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory studyMatthias Papo, Chloé Friedrich, Laure Delaval, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Diagnostics (Basel, Switzerland)|July 27, 2022
The Mesenchymal Niche in Myelodysplastic SyndromesChloé Friedrich, Olivier Kosmider
Blood|July 3, 2020
A splenic lymphoma/leukemia with a spontaneous blast decrease without treatmentChloé Friedrich, Sylvain Barreau
Annals of Hematology|June 14, 2020
Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndromeChloé Friedrich, Juliette Gay, Anne-Sophie Alary, et al.
Annals of Hematology|October 4, 2022
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromesMeunier Mathieu, Chloé Friedrich, Nicolas Ducrot, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Rheumatology (Oxford, England)|July 2, 2021
Atypical splice-site mutations causing VEXAS syndromeMarie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
BMC Biology|March 9, 2022
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell levelCharles Dussiau, Agathe Boussaroque, Mathilde Gaillard, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
Rheumatology (Oxford, England)|April 9, 2021
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory studyMatthias Papo, Chloé Friedrich, Laure Delaval, et al.
Pageof 2